Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis.
about
Nanoparticulate carriers for the treatment of coronary restenosisCurrent advances in research and clinical applications of PLGA-based nanotechnology.Nanotechnology and medicine.Gene therapy for the prevention of vein graft diseaseTargeted nanoparticle-based drug delivery and diagnosis.Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.Oligonucleotide delivery in cancer therapy.Nanomedicine in cardiovascular therapy: recent advancements.Role of biomaterials in prevention of in-stent restenosis.Non-covalent complexes of folic acid and oleic acid conjugated polyethylenimine: An efficient vehicle for antisense oligonucleotide delivery.Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells.Biodistribution of antisense nanoparticles in mammary carcinoma rat model.Navigare necessere est. Improved navigation would help to solve two crucial problems in modern drug therapy: toxicity and precise delivery.Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides.Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions.
P2860
Q28220309-F9093A7E-4C16-40F1-B0AA-CE828A1C9A7AQ30482916-7DB06475-B28A-4733-B758-E18933AF8F12Q35164817-7D176243-99E4-400E-A3CA-04DD6CE6030DQ36698258-45175E9D-CBE8-4597-84D0-212A87418738Q36799773-26612507-3ACF-4254-BD3F-A20DCFF240CCQ37444136-FC99D065-CA6C-4288-8AB8-96D11A1911A8Q37511128-89B65AB5-B020-47F4-8D4A-6892EAA557A5Q37803214-49552FF0-557E-4B4A-BE35-029B1EA1B88CQ38034812-FBDB9E8A-C0EF-4043-BE2F-34C1B6AE1826Q38168808-0F99B5A9-BAFB-4854-8FE2-F561E27A75ADQ38844509-4923F4A6-A92E-4741-9746-82B7D8B229DDQ39664012-D1C32D19-8A53-4412-8CD0-D5E62821F1F4Q39709283-62FAF8CF-F99A-4DCB-B9C1-7A7521235063Q42919601-29DF278E-A3EC-4C9D-B35D-3A6CB9A629B9Q43143238-250F1FD4-9BDD-4373-BB06-28EF91EEAD72Q53646030-EBE876E3-E9F0-481A-A6E8-2D192D8CFC3D
P2860
Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Novel PDGFbetaR antisense enca ...... r the treatment of restenosis.
@en
Novel PDGFbetaR antisense enca ...... r the treatment of restenosis.
@nl
type
label
Novel PDGFbetaR antisense enca ...... r the treatment of restenosis.
@en
Novel PDGFbetaR antisense enca ...... r the treatment of restenosis.
@nl
prefLabel
Novel PDGFbetaR antisense enca ...... r the treatment of restenosis.
@en
Novel PDGFbetaR antisense enca ...... r the treatment of restenosis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Novel PDGFbetaR antisense enca ...... or the treatment of restenosis
@en
P2093
Cohen-Sacks H
Tchaikovski V
P2860
P2888
P304
P356
10.1038/SJ.GT.3301830
P577
2002-12-01T00:00:00Z
P5875
P6179
1012009078